In situ detection of tissue factor within the coronary intima in rat cardiac allograft vasculopathy

American Journal of Pathology

Volumn 154, Issue 1, 1999, Pages 211-220

  Hölschermann, Hans ^a   Bohle, Rainer M ^a   Zeller, Hagen ^a   Schmidt, Heiko ^a   Stahl, Ulrich ^a   Fink, Ludger ^a   Grimm, Helmut ^a   Tillmanns, Harald ^a   Haberbosch, Werner ^b  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b KERCKHOFF HEART CENTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; MESSENGER RNA; THROMBOPLASTIN;

ADVENTITIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; ENDOTHELIUM LESION; FIBRIN FORMATION; HEART TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; INTIMA; MALE; MONONUCLEAR CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0345471355     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65267-4     Document Type: Article

References (62)

1. Weis M, von Scheidt W: Cardiac allograft vasculopathy. Circulation 1997, 96:2069-2077
2. Kaye MP: The Registry of the International Society for Heart and Lung Transplantation: Tenth Official Report, 1993. J Heart Lung Transplant 1993, 12:541-548
3. Gao SZ, Schroeder JS, Alderman EL, Hunt SA, Valantine HA, Wiederhold V, Stinson EB: Prevalence of accelerated coronary artery disease in heart transplant survivors: comparison of cyclosporine and azathioprine regimens. Circulation 1989, 80:100-105
4. Hakim M, Wallwork J, English T: Cyclosporin A in cardiac transplantation: medium-term results in 62 patients. Ann Thorac Surg 1988, 46:495-501
5. Billingham ME: Cardiac transplant atherosclerosis. Transplant Proc 1987, 19:19-25
6. Hruban RH, Beschorner WE, Baumgartner WA, Augustine SM, Reitz BA, Hutchins GM: Accelerated arteriosclerosis in heart transplant recipients: an immunopathology study of 22 transplanted hearts. Transplant Proc 1991, 223:1230
7. Louie HW, Pang M, Lewis W, Drinkwater DC, Laks H: Immunhistochemical analysis of accelerated graft atherosclerosis in cardiac transplantation. Curr Surg 1989, 46:479
8. Paavonen T, Mennander A, Lautenschlager I, Mattila S, Hayry P: Endothelialitis and accelerated arteriosclerosis in human heart transplant coronaries. J Heart Lung Transplant 1993, 12:117
9. Wenke K, Meiser B, Thiery J, Nagel D, Scheidt Wv, Steinbeck G, Seidel D, Reichart B: Simvastatin reduces graft vessel disease and mortality after heart transplantation. Circulation 1997, 96:1398-1402
10. Gao SZ, Alderman EL, Schroeder JS, Silverman JF, Hunt SA: Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings. J Am Coll Cardiol 1988, 12:334-340
11. Faulk WP, Labarrere CA: Vascular immunopathology and atheroma development in human allografted organs. Arch Pathol Lab Med 1992, 116:1337-1344
12. Labarrere CA, Pitts D, Nelson DR, Faulk W: Page vascular tissue plasminogen activator and the development of coronary artery disease in heart-transplant recipients. N Engl J Med 1995, 333:1111-1116
13. Arbustini E, Roberts WC: Morphological observations in the epicardial coronary arteries and their surroundings late after cardiac transplantation. Am J Cardiol 1996, 78:814-820
14. Rabbani LE, Loscalzo J: Recent observations on the role of hemostatic determinants in the development of the atherothrombotic plaque. Atherosclerosis 1994, 105:1-7
15. Weiss RH, Maduri M: The mitogenic effect of thrombin in vascular smooth muscle cells is largely due to basic fibroblast growth factor. J Biol Chem 1993, 268:5724-5727
16. Smith EB, Thompson WD: Fibrin as a factor in atherogenesis. Thromb Res 1994, 73:1-19
17. Nemerson Y: Tissue factor and hemostasis. Blood 1988, 71:71-78
18. Wilcox JN, Smith KM, Schwartz SM, Gordon D: Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque Proc Natl Acad Sci USA 1989, 86:2839-2843
19. Drake TA, Morrissey JH, Edgington TS: Selectve cellular expression of tissue factor in human tissues. Am J Pathol 1989, 134:1089-1097
20. Scarpati EM, Sadler JE: Regulation of endothelial cell coagulation properties. J Biol Chem 1989, 264:20705-20713
21. Nawroth PP, Handley DA, Esmon CT, Stern DM: Interleukin 1 induces endothelial cell procoagulant activity while suppressing cell-surface anticoagulant activity. Proc Natl Acad Sci USA 1986, 83:3460-3464
22. Bierhaus A, Zhang Y, Deng Y, Mackman N, Quehenberger P, Haase M, Luther T, Müller M, Böhrer H, Greten J, Eike M, Bauerle P, Waldherr R, Kisiel W, Ziegler R, Stern DM, Nawroth PP: Mechanism of the TNFα mediated induction of endothelial tissue factor. J Biol Chem 1995, 270:26419-26432
23. Edgington TS, Mackman N, Brand K, Ruf W: The structural biology of expression and function of tissue factor. Thromb Haemost 1991, 66:67-79
24. Fan S-T, Mackman N, Cui M-Z, Edgington TS: Integrin regulation of an inflammatory effector gene: direct induction of the tissue factor promoter by engagement of β1 or α4 integrin chains. J Immunol 1995, 154:3266-3274
25. Gregory SA, Kornbluth RS, Helin H, Remold HG, Edgington TS: Monocyte pro-coagulant inducing factor: a lymphokine involved in the T-cell instructed monocyte pro-coagulant response to antigen. J Immunol 1986, 141:3231-3239
26. Bloem LJ, Chen L, Konigsberg WH, Bach R: Serum stimulation of quiescent human fibroblasts induces the synthesis of TF mRNA followed by the appearance of tissue factor antigen and procoagulant activity. J Cell Physiol 1989, 139:418-423
27. 2+ mobilization and protein kinase C activation. J Clin Invest 1993, 91:547-552
28. Heron I: A technique for accessory cervical heart transplantation in rabbits and rats. Acta Pathol Scand 1973, 79:366
29. Cordell JL, Falini B, Erber WN, Gosh AK, Abdulaziz Z, MacDonald S, Pulford KAF, Stein H, Mason DY: Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984, 32:219-229
30. Sarris GE, Mitchell RS, Billingham ME, Glasson JR, Cahill PD, Miller DC: Inhibition of accelerated cardiac allograft arteriosclerosis by fish oil. J Thorac Cardiovasc Surg 1989, 97:841-855
31. Lurie KG, Billingham ME, Jamieson SW, Harrison DC, Reitz BA: Pathogenesis and prevention of graft atherosclerosis in an rat experimental heart transplantation model. Transplantation 1981, 31:41-47
32. Pawashe AB, Paolo G, Ambrosio G, Migliaccio F, Ragni M, Immacolata P, Chiariello M, Bach R, Garen A, Konigsberg WK, Ezekowitz MD: A monoclonal antibody against rabbit tissue factor inhibits thrombus formation in stenotic injured rabbit carotid arteries. Circ Res 1994, 74:56-63
33. Kwok S: Procedures to minimize PCR-product carryover. PCR Protocols: A Guide to Methods and Applications. Edited by Innis MA, Gelfand DH, Snisky JJ, White TJ, San Diego, Academic Press, 1990, pp 142-145
34. Becker I, Becker HF, Röhrl HH, Höfler H: Laser-assisted preparation of single-cells from stained histological slides. Histochem Cell Biol 1997, 108:448-451
35. Schütze K, Lahr G: Identification of expressed genes by laser-mediated manipulation of single cells. Nature Biotechnol 1998, 16:737-742
36. Brady G, Iscove NN: Construction of cDNA libraries from single cells. Methods Enzymol 1993, 225:661-623
37. Adams DH, Tilney ML, Collins JJJ, Karnovsky MJ: Experimental graft arteriosclerosis. Transplantation 1992, 53:1115-1119
38. Billingham ME. Histopathology of graft coronary disease. J Heart Lung Transplant 1992, 11:S38-S44
39. Labarrere CA, Pitts D, Halbrook H, Faulk WP: Tissue plasminogen activator, plasminogen activator inhibitor-1, and fibrin as indexes of clinical course in cardiac allograft recipients an immunocytochemical study. Circulation 1994, 89:1599-1608
40. Bach RR: Initiation of coagulation by tissue factor. CRC Crit Rev Biochem 1988, 23:339-368
41. Osterud B, Flaestad T: Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: related to an unfavorable prognosis. Thromb Haemost 1983, 49:5-7
42. Rao LVM: Tissue factor as a tumor procoagulant. Cancer Metastasis Rev 1992, 11:249-266
43. Taylor FBJ, Chang A, Ruf W, Morrissey JH, Hinshaw L, Catlett R, Blick K, Edgington TS: Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock 1991, 33:127-134
44. Camerer E, Kolsto A, Prydz H: Cell biology of tissue factor, the principal initiator of blood coagulation. Thromb Res 1996, 81:1-41
45. Hatakeyama K, Asada Y, Marutsuka K, Sato Y, Kamikubo Y, Sumiyoshi A: Localization and activity of tissue factor in human aortic atherosclerotic lesions. Atherosclerosis 1997, 133 213-219
46. Contrino J, Hair G, Kreutzer DL, Rickles FR: In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nature Med 1996, 2:209-215
47. Thiruvikraman SV, Guha A, Roboz J, Taubman MB, Nemerson Y, Fallon JT: In situ localization of tissue factor in human atherosclerotic plaques by binding of digoxigenin-labeled factors VIIa and X. Lab Invest 1996, 75:451-461
48. Drake TA, Cheng J, Chang A, Taylor FBJ: Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. Am J Pathol 1993, 142:1458-1470
49. Salom RN, Maguire JA, Hancock WW: Endothelial activation and cytokine expression in human acute cardiac allograft rejection. Pathology 1998, 30:24-29
50. Colcucci M, Balconi G, Lorenzet R, Pietra A, Locati D, Donati MB, Semeraro N: Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest 1983, 71:1893-1896
51. Drake TA, Hannani K, Fei HH, Lavi S, Berliner JA: Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells. Am J Pathol 1991, 138:601-607
52. Gertler JP, Weibe DA, Ocasio VH, Abbott WM: Hypoxia induces procoagulant activity in cultured human venous endothelium. J Vasc Surg 1991, 1991:428-433
53. Carlsen E, Flatmark A, Prydz H: Cytokine-induced procoagulant activity in monocytes and endothelial cells: further enhancement by cyclosporine. Transplantation 1988, 46:575-580
54. Clauss M, Gerlach M, Gerlach H, Brett J, Wang F, Familletti PC, Pan YC, Olander JV, Connolly DT, Stern D: Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity and promotes monocyte migration. J Exp Med 1990, 172:535-545
55. Tannenbaum SH, Finko R, Cines DB: Antibody and immune complexes induce tissue factor production by human endothelial cells. J Immunol 1986, 137:1532-1537
56. Lyberg T, Galdal KS, Evensen SA, Prydz H: Cellular cooperation in endothelial cell thromboplastin synthesis. Br J Haematol 1983, 53: 85-95
57. Hölschermann H, Kohl O, Maus U, Dürfeld F, Bierhaus A, Nawroth PP, Lohmeyer J, Tillmanns H, Haberbosch W: Cyclosporine inhibits monocyte tissue factor activation in cardiac transplant recipients. Circulation 1997, 96:4232-4238
58. Helin H, Edgington TS: Allogeneic induction of the human T cell-instructed monocyte procoagulant response is rapid and is elicited by HLA-DR. J Exp Med 1983, 158:962-975
59. Ferreira OC Jr, Barcinski MA: Autologous induction of the human T-cell-dependent monocyte procoagulant activity: a possible link between immunoregulatory phenomena and blood coagulation. Cell Immunol 1986, 101:259-265
60. Tanaka K, Sueishi K: Biology of disease: the coagulation and fibrinolysis systems and atherosclerosis. Lao Invest 1993, 69:5-18
61. Thompson WD, Smith EB: Atherosclerosis and the coagulation system. J Pathol 1989, 159:97-106
62. Sato Y, Asada Y, Marutsuka K, Hatakeyama K, Sumiyoshi A: Tissue factor induces migration of cultured aortic smooth muscle cells. Thromb Haemost 1996, 75:389-392